Please login to the form below

Not currently logged in
Email:
Password:

Prix Galien

This page shows the latest Prix Galien news and features for those working in and with pharma, biotech and healthcare.

Orphan drugs from Biogen and Amicus win UK Prix Galien

Orphan drugs from Biogen and Amicus win UK Prix Galien

Spinraza’s Prix Galien victory is well deserved and was the unanimous decision of the judging panel.”. ... conditions," said Karen Westaway, Chief Executive of ValueBase, owners of Prix Galien’s UK franchise.

Latest news

  • Orphan drugs dominate UK Prix Galien shortlist, medtech debuts Orphan drugs dominate UK Prix Galien shortlist, medtech debuts

    The shortlist was drawn up by the UK Prix Galien’s independent panel of distinguished physicians, chaired by former NICE chairman Sir Michael Rawlins. ... Karen Westaway, Chief Executive of ValueBase – owners of Prix Galien’s UK franchise – said:

  • Prix Galien opens for entries with new award Prix Galien opens for entries with new award

    2018 programme will include new medical technology category. Entries have opened for the 2018 UK Prix Galien Awards. ... Previous UK Prix Galien winners include well-known brands such as Viagra, Herceptin, Glivec, Xolair, Bexero, Cervarix and Gardasil.

  • NICE backs Europe's first stem cell therapy NICE backs Europe's first stem cell therapy

    Holoclar - which won the UK Prix Galien award in 2016 - is the first product from Chiesi's nine-year-old rare disease unit to reach the market, although it could shortly

  • Chiesi's Holoclar wins UK Prix Galien orphan drug award Chiesi's Holoclar wins UK Prix Galien orphan drug award

    LSCD). Professor Sir Michael Rawlins, chair of the UK Prix Galien judges, said: “LSCD may affect one or both eyes; left untreated it results in chronic pain, photophobia, inflammation, corneal neovascularisation ... It marks the fourth UK Prix Galien

  • AZ, BMS and Boehringer among UK Prix Galien finalists AZ, BMS and Boehringer among UK Prix Galien finalists

    They join Alexion, Chiesi, Janssen, Novartis, Otsuka and Takeda. Novartis awarded 2014 UK Prix Galien for Bexser. ... AstraZeneca, Bristol-Myers Squibb and Boehringer Ingelheim are among the finalists for the 2016 UK Prix Galien Awards.

More from news
Approximately 8 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • The world is our laboratory The world is our laboratory

    We developed Sirturo (bedaquiline), the first new medicine for tuberculosis in 40 years, which received the UK Prix Galien Award for most innovative orphan drug in October 2014.

  • Interview: Cesar Rodriguez, Janssen Interview: Cesar Rodriguez, Janssen

    Rodriguez also references infectious diseases as a stronghold for the company, mentioning the victory for hepatitis C treatment telaprevir in the 2012 UK Prix Galien Innovative Product Award.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics